Palisade Capital Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-17,000
Closed -$968K 433
2021
Q3
$968K Buy
+17,000
New +$1.03M 0.02% 334
2020
Q2
Sell
-13,500
Closed -$324K 400
2020
Q1
$324K Buy
+13,500
New +$389K 0.01% 371
2019
Q4
Sell
-13,500
Closed -$312K 425
2019
Q3
$312K Buy
+13,500
New +$283K 0.01% 383
2019
Q1
Sell
-66,000
Closed -$899K 448
2018
Q4
$899K Hold
66,000
0.03% 341
2018
Q3
$1M Hold
66,000
0.03% 357
2018
Q2
$1.14M Buy
+66,000
New +$1.27M 0.03% 336

Other funds holding LRCX

Palisade Capital Management's LRCX Position: Q4 2021 in Review

Palisade Capital Management sold out of Lam Research (LRCX) in Q4 2021, closing a stake of 17,000 shares — an estimated $968K sold.

Palisade Capital Management first reported a position in LRCX in Q2 2018 and held it in 6 quarters. The position peaked at $1.14M in Q2 2018. 1,460 funds tracked by Wall St. Rank hold LRCX as of Q4 2021.

  • Palisade Capital Management reported no remaining Lam Research position as of Q4 2021 after selling out during the quarter.
  • Palisade Capital Management sold 17,000 Lam Research shares in Q4 2021, an estimated $968K.
  • Palisade Capital Management first reported a position in Lam Research in Q2 2018 and held it in 6 quarters.
  • Palisade Capital Management's Lam Research position peaked at $1.14M in Q2 2018.
  • 1,460 funds tracked by Wall St. Rank held Lam Research as of Q4 2021.

Based on Palisade Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.